Intrarenal FXR overexpression in HFS-fed mice and FXR agonist treatments in mIMCD-K2 cells attenuate hypertension and promote NO production by regulating the expression of dynamin 3 (DNM3), which is a binding protein with neuronal NOS in the renal medulla27. Here, DNM3 is linked to hypertensive disorder.